Zynx Update March 2013

 

Updated Content


Order Set Updates (Immediate Attention Required)
For instructions, click here.

Withdrawn Evidence Links

  • Chest Pain – Nonurgent

    • Ambulatory Management

      • Complete blood cell count with automated white blood cell differential
      • Glucose, serum, fasting

  • Coronary Artery Disease – Stable

    • Ambulatory Management

      • Complete blood cell count with automated white blood cell differential
      • For patients with a history of prior GI bleeding who require dual antiplatelet therapy, a PPI should be used
      • For patients with an increased risk of GI bleeding who require dual antiplatelet therapy, consider a PPI
      • Glucose, serum, fasting
      • Hemoglobin A1c (HbA1c)
      • Radiograph, chest, 2 views
      • Routine use of a PPI in patients requiring dual antiplatelet therapy who are at low risk for GI bleeding

  • Diabetes Mellitus – Pediatric

    • Ambulatory Management

      • Consult to nephrology
      • Consult to podiatry

  • Pneumonia – CAP, Adult

    • Ambulatory Management

      • Basic metabolic panel
      • Complete blood cell count with automated white blood cell differential
      • Routine use of sputum culture
      • Routine use of sputum Gram staining

  • Syncope

    • Ambulatory Management

      • History and physical examination

  • Urinary Incontinence

    • Ambulatory Management

      • Increasing physical activity for patients with or at risk for urinary incontinence

Split Evidence Links

  • There are no split evidence links.


Other Updates
New Modules

  • There are no new modules.

New Evidence Topics

  • Chest Pain – Nonurgent: Stress Radionuclide Imaging
  • Coronary Artery Disease – Stable: Disease Management
  • Coronary Artery Disease – Stable: ECG
  • Deep Venous Thrombosis – Treatment: Unfractionated Heparin
  • Depression: Internet-Based Program
  • Depression: Music Therapy
  • Diabetes Mellitus – Adult: Insulin Pen Therapy
  • Dyslipidemia: Hormone Replacement Therapy
  • Gastrointestinal Bleeding – Lower: CT – Enterography
  • Hepatitis C – Chronic: Consult – Addiction Specialist
  • Hepatitis C – Chronic: ECG
  • Hepatitis C – Chronic: History and Physical Examination
  • Hepatitis C – Chronic: IL28B Genotype Testing
  • Hepatitis C – Chronic: Liver Function Tests
  • Hepatitis C – Chronic: Uric Acid
  • Osteoporosis/Osteopenia: Bone Turnover Markers
  • Osteoporosis/Osteopenia: History and Physical Examination
  • Otitis Media – Pediatric: Lincosamides
  • Preoperative Care: Initial Assessment
  • Preventive Care and Screening – Adult: Beta-Blockers
  • Preventive Care and Screening – Pediatric: Maternal
  • Preventive Care and Screening – Pediatric: Pediatric
  • Urinary Tract Infection – Adult: History and Physical Examination

 

Back to the Top

> E-mail this page

 


FDA Drug Safety Alerts
 

Click here for FDA Safety Alerts relevant to Zynx evidence.
_
Zynx Update does not address the addition, deletion, or modification of clinical rules, nor does it address the addition of items or the deletion of non–evidence-based items from order sets or plans of care. Zynx Update is intended for use by quality improvement personnel who can review the information provided to help decide if modifications should be made to existing order sets, plans of care, and rules, based on changes to the evidence.